Author:
Brufman G.,Haim N.,Ben-Baruch N.,Sulkes A.
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference19 articles.
1. Durr FC. Biologic and biochemical effects of Mitoxantrone. Semin Oncol 1984; 11: 3–10.
2. Anderson KC, Cohen GI, Garnick MB. Phase II trial of Mitoxantrone. Cancer Treat Rep 1982; 66: 1929–1931.
3. Wallace RE, Murdock KC, Angier BB et al. Activity of a novel anthracenedione l,4-dihydroxy-5,8,bis (2-((2-hydroxy-ethyl) amino)- ethylamino)-9,10-anthracenedione dihydrochloride against experimental tumors in mice. Cancer Res 1979; 39: 1570–1574.
4. Ingle JN, Green SJ, Brunk SF et al. Randomized clinical trials of Doxorubicin alone or combined with Mitolactol in women with advanced breast cancer and prior chemotherapy exposure. Am J Clin Oncol 1985; 8: 275–282.
5. Cornbleet MA, Stuart-Harris RC, Smith IE. Mitoxantrone for the treatment of advanced breast cancer: single agent therapy in previously untreated patients. Eur J Cancer Clin Oncol 1984; 20: 1141–1146.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献